Olema Pharmaceuticals, Inc.
OLMA
20 insider filings · Latest: Jun 18, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Mar 16 8:03 PM | Kovacs Shane William Charles | Proposed Sale | 4,166 | $16.61 | $69.2K | — | View → |
| Mar 16, 2026 | Mar 16 4:43 PM | Kovacs Shane William Charles | Proposed Sale | 100,000 | $16.08 | $1.6M | — | View → |
| Mar 11, 2026 | Mar 11 8:20 PM | Kovacs Shane William Charles | Proposed Sale | 50,000 | $15.94 | $796.8K | — | View → |
| Mar 10, 2026 | Mar 10 4:27 PM | Kovacs Shane William Charles | Proposed Sale | 53,206 | $17.00 | $904.6K | — | View → |
| Mar 9, 2026 | Mar 9 7:16 PM | Kovacs Shane William Charles | Proposed Sale | 241,999 | $13.45 | $3.3M | — | View → |
| Mar 4, 2026 | Mar 6 1:00 AM | Shawnte MitchellCHIEF LEGAL OFFICER | Sale | 25,000 | $24.25 | $606.4K | 0(D) | View → |
| Mar 3, 2026 | Mar 6 1:00 AM | Shawnte MitchellCHIEF LEGAL OFFICER | Sale | 15,000 | $23.01 | $345.1K | 0(D) | View → |
| Mar 4, 2026 | Mar 4 7:19 PM | Kovacs Shane William Charles | Proposed Sale | 20,000 | $24.43 | $488.7K | — | View → |
| Mar 4, 2026 | Mar 4 3:21 PM | Mitchell Shawnte | Proposed Sale | 25,000 | $23.94 | $598.5K | — | View → |
| Mar 3, 2026 | Mar 3 7:59 PM | Mitchell Shawnte | Proposed Sale | 15,000 | $23.01 | $345.2K | — | View → |
| Feb 27, 2026 | Feb 27 9:38 PM | Kovacs Shane William Charles | Proposed Sale | 6,521 | $25.00 | $163.0K | — | View → |
| Feb 24, 2026 | Feb 24 8:46 PM | Kovacs Shane William Charles | Proposed Sale | 20,000 | $25.00 | $500.0K | — | View → |
| Feb 23, 2026 | Feb 23 9:33 PM | Kovacs Shane William Charles | Proposed Sale | 10,000 | $24.30 | $243.0K | — | View → |
| Feb 23, 2026 | Feb 23 7:34 PM | Kovacs Shane William Charles | Proposed Sale | 20,000 | $24.00 | $480.0K | — | View → |
| Feb 12, 2026 | Feb 12 7:55 PM | Kovacs Shane William Charles | Proposed Sale | 10,000 | $23.85 | $238.5K | — | View → |
| Jan 20, 2026 | Jan 22 2:00 AM | Cyrus HarmonDirector | Sale | 10,000 | $26.88 | $268.8K | 727,770(D) | View → |
| Jan 20, 2026 | Jan 20 9:13 PM | Harmon Cyrus | Proposed Sale | 10,000 | $26.88 | $268.8K | — | View → |
| Jan 14, 2026 | Jan 17 2:00 AM | Cyrus HarmonDirector | Sale | 3,489 | $29.12 | $101.6K | 737,770(D) | View → |
| Jan 15, 2026 | Jan 15 9:22 PM | Kovacs Shane William Charles | Proposed Sale | 100,000 | $28.73 | $2.9M | — | View → |
| Jan 14, 2026 | Jan 14 9:20 PM | Harmon Cyrus | Proposed Sale | 3,489 | $29.12 | $101.6K | — | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | Jun 23 9:52 PM | P/Il L Bvf PartnersDirector, Other | Grant/Award | 29,500 | $9.51 | 29,500(I) | View → |
| Jun 18, 2026 | Jun 23 9:30 PM | Cyrus HarmonDirector | Grant/Award | 29,500 | $9.51 | 29,500(D) | View → |
| Jun 18, 2026 | Jun 23 9:29 PM | Cynthia M ButittaDirector | Grant/Award | 29,500 | $9.51 | 29,500(D) | View → |
| Jun 18, 2026 | Jun 23 9:28 PM | Scott J. GarlandDirector | Grant/Award | 29,500 | $9.51 | 29,500(D) | View → |
| Jun 18, 2026 | Jun 23 9:27 PM | Gorjan HrustanovicDirector | Grant/Award | 29,500 | $9.51 | 29,500(D) | View → |
| Jun 18, 2026 | Jun 23 9:26 PM | Ian T ClarkDirector | Grant/Award | 29,500 | $9.51 | 29,500(D) | View → |
| Jun 18, 2026 | Jun 23 9:25 PM | Yi LarsonDirector | Grant/Award | 29,500 | $9.51 | 29,500(D) | View → |
| Jun 18, 2026 | Jun 23 9:24 PM | Sandra HorningDirector | Grant/Award | 29,500 | $9.51 | 29,500(D) | View → |
| Jun 18, 2026 | Jun 23 9:23 PM | Prakash RamanDirector | Grant/Award | 29,500 | $9.51 | 29,500(D) | View → |
| Jun 18, 2026 | Jun 23 9:22 PM | Andrew RappaportDirector | Grant/Award | 29,500 | $9.51 | 29,500(D) | View → |
| Jun 18, 2026 | Jun 23 9:21 PM | Graham G. WalmsleyDirector | Grant/Award | 29,500 | $9.51 | 29,500(D) | View → |
| Apr 28, 2026 | Apr 29 11:53 PM | Prakash RamanDirector | Grant/Award | 27,061 | $14.59 | 24,150(D) | View → |
| Mar 4, 2026 | Mar 6 1:00 AM | Shawnte MitchellCHIEF LEGAL OFFICER | Option Exercise | 25,000 | $4.37 | 410,000(D) | View → |
| Mar 3, 2026 | Mar 6 1:00 AM | Shawnte MitchellCHIEF LEGAL OFFICER | Option Exercise | 15,000 | $4.37 | 435,000(D) | View → |
| Feb 2, 2026 | Feb 18 2:35 AM | Sasha Lu AustinVP of Finance and Controller | Grant/Award | 29,250 | $25.65 | 29,250(D) | View → |
| Feb 2, 2026 | Feb 5 2:30 AM | Naseem ZojwallaCHIEF MEDICAL OFFICER | Grant/Award | 356,250 | $25.65 | 106,250(D) | View → |
| Feb 2, 2026 | Feb 5 2:30 AM | David C. MylesCH. DISCOV. & NON-CLIN DEV OFF | Grant/Award | 356,250 | $25.65 | 106,250(D) | View → |
| Feb 2, 2026 | Feb 5 2:30 AM | Shawnte MitchellCHIEF LEGAL OFFICER | Grant/Award | 276,250 | $25.65 | 56,250(D) | View → |
| Feb 2, 2026 | Feb 5 2:30 AM | Sean BohenDirector, PRESIDENT AND CEO | Grant/Award | 1,125,000 | $25.65 | 275,000(D) | View → |